479 related articles for article (PubMed ID: 32054768)
1. Adipocyte-Induced FABP4 Expression in Ovarian Cancer Cells Promotes Metastasis and Mediates Carboplatin Resistance.
Mukherjee A; Chiang CY; Daifotis HA; Nieman KM; Fahrmann JF; Lastra RR; Romero IL; Fiehn O; Lengyel E
Cancer Res; 2020 Apr; 80(8):1748-1761. PubMed ID: 32054768
[TBL] [Abstract][Full Text] [Related]
2. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth.
Nieman KM; Kenny HA; Penicka CV; Ladanyi A; Buell-Gutbrod R; Zillhardt MR; Romero IL; Carey MS; Mills GB; Hotamisligil GS; Yamada SD; Peter ME; Gwin K; Lengyel E
Nat Med; 2011 Oct; 17(11):1498-503. PubMed ID: 22037646
[TBL] [Abstract][Full Text] [Related]
3. Adipocytes promote cholangiocarcinoma metastasis through fatty acid binding protein 4.
Nie J; Zhang J; Wang L; Lu L; Yuan Q; An F; Zhang S; Jiao Y
J Exp Clin Cancer Res; 2017 Dec; 36(1):183. PubMed ID: 29237483
[TBL] [Abstract][Full Text] [Related]
4. FABP4 as a key determinant of metastatic potential of ovarian cancer.
Gharpure KM; Pradeep S; Sans M; Rupaimoole R; Ivan C; Wu SY; Bayraktar E; Nagaraja AS; Mangala LS; Zhang X; Haemmerle M; Hu W; Rodriguez-Aguayo C; McGuire M; Mak CSL; Chen X; Tran MA; Villar-Prados A; Pena GA; Kondetimmanahalli R; Nini R; Koppula P; Ram P; Liu J; Lopez-Berestein G; Baggerly K; S Eberlin L; Sood AK
Nat Commun; 2018 Jul; 9(1):2923. PubMed ID: 30050129
[TBL] [Abstract][Full Text] [Related]
5. Identification of a potential biomarker for FABP4 inhibition: the power of lipidomics in preclinical drug testing.
Suhre K; Römisch-Margl W; de Angelis MH; Adamski J; Luippold G; Augustin R
J Biomol Screen; 2011 Jun; 16(5):467-75. PubMed ID: 21543640
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic and tumour inhibitory effects of downregulating tumour endothelial FABP4.
Harjes U; Bridges E; Gharpure KM; Roxanis I; Sheldon H; Miranda F; Mangala LS; Pradeep S; Lopez-Berestein G; Ahmed A; Fielding B; Sood AK; Harris AL
Oncogene; 2017 Feb; 36(7):912-921. PubMed ID: 27568980
[TBL] [Abstract][Full Text] [Related]
7. Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis.
Ladanyi A; Mukherjee A; Kenny HA; Johnson A; Mitra AK; Sundaresan S; Nieman KM; Pascual G; Benitah SA; Montag A; Yamada SD; Abumrad NA; Lengyel E
Oncogene; 2018 Apr; 37(17):2285-2301. PubMed ID: 29398710
[TBL] [Abstract][Full Text] [Related]
8. RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice.
Yang R; Castriota G; Chen Y; Cleary MA; Ellsworth K; Shin MK; Tran JL; Vogt TF; Wu M; Xu S; Yang X; Zhang BB; Berger JP; Qureshi SA
Int J Obes (Lond); 2011 Feb; 35(2):217-25. PubMed ID: 20603627
[TBL] [Abstract][Full Text] [Related]
9. Adipokine Apelin/APJ Pathway Promotes Peritoneal Dissemination of Ovarian Cancer Cells by Regulating Lipid Metabolism.
Dogra S; Neelakantan D; Patel MM; Griesel B; Olson A; Woo S
Mol Cancer Res; 2021 Sep; 19(9):1534-1545. PubMed ID: 34172534
[TBL] [Abstract][Full Text] [Related]
10. Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells.
Rabelo-Fernández RJ; Santiago-Sánchez GS; Sharma RK; Roche-Lima A; Carrion KC; Rivera RAN; Quiñones-Díaz BI; Rajasekaran S; Siddiqui J; Miles W; Rivera YS; Valiyeva F; Vivas-Mejia PE
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008958
[TBL] [Abstract][Full Text] [Related]
11. FABP4 inhibitor BMS309403 decreases saturated-fatty-acid-induced endoplasmic reticulum stress-associated inflammation in skeletal muscle by reducing p38 MAPK activation.
Bosquet A; Girona J; Guaita-Esteruelas S; Heras M; Saavedra-García P; Martínez-Micaelo N; Masana L; Rodríguez-Calvo R
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Jun; 1863(6):604-613. PubMed ID: 29550588
[TBL] [Abstract][Full Text] [Related]
12. IL-17A promotes fatty acid uptake through the IL-17A/IL-17RA/p-STAT3/FABP4 axis to fuel ovarian cancer growth in an adipocyte-rich microenvironment.
Yu C; Niu X; Du Y; Chen Y; Liu X; Xu L; Iwakura Y; Ma X; Li Y; Yao Z; Deng W
Cancer Immunol Immunother; 2020 Jan; 69(1):115-126. PubMed ID: 31802182
[TBL] [Abstract][Full Text] [Related]
13. Adipocytes induce the resistance of ovarian cancer to carboplatin through ANGPTL4.
Zhou S; Wang R; Xiao H
Oncol Rep; 2020 Sep; 44(3):927-938. PubMed ID: 32705217
[TBL] [Abstract][Full Text] [Related]
14. FABP4 inhibition suppresses PPARγ activity and VLDL-induced foam cell formation in IL-4-polarized human macrophages.
Boss M; Kemmerer M; Brüne B; Namgaladze D
Atherosclerosis; 2015 Jun; 240(2):424-30. PubMed ID: 25897794
[TBL] [Abstract][Full Text] [Related]
15. Does TP53 mutation promote ovarian cancer metastasis to omentum by regulating lipid metabolism?
Hu J; Liu Z; Wang X
Med Hypotheses; 2013 Oct; 81(4):515-20. PubMed ID: 23880140
[TBL] [Abstract][Full Text] [Related]
16. Group III phospholipase A2 downregulation attenuated survival and metastasis in ovarian cancer and promotes chemo-sensitization.
Ray U; Roy D; Jin L; Thirusangu P; Staub J; Xiao Y; Kalogera E; Wahner Hendrickson AE; Cullen GD; Goergen K; Oberg AL; Shridhar V
J Exp Clin Cancer Res; 2021 Jun; 40(1):182. PubMed ID: 34082797
[TBL] [Abstract][Full Text] [Related]
17. Fatty Acid-Binding Protein 4 mediates apoptosis via endoplasmic reticulum stress in mesangial cells of diabetic nephropathy.
Yao F; Li Z; Ehara T; Yang L; Wang D; Feng L; Zhang Y; Wang K; Shi Y; Duan H; Zhang L
Mol Cell Endocrinol; 2015 Aug; 411():232-42. PubMed ID: 25958041
[TBL] [Abstract][Full Text] [Related]
18. A critical role of Oct4A in mediating metastasis and disease-free survival in a mouse model of ovarian cancer.
Samardzija C; Luwor RB; Volchek M; Quinn MA; Findlay JK; Ahmed N
Mol Cancer; 2015 Aug; 14():152. PubMed ID: 26260289
[TBL] [Abstract][Full Text] [Related]
19. Establishment and characterization of a platinum- and paclitaxel-resistant high grade serous ovarian carcinoma cell line.
Teng PN; Bateman NW; Wang G; Litzi T; Blanton BE; Hood BL; Conrads KA; Ao W; Oliver KE; Darcy KM; McGuire WP; Paz K; Sidransky D; Hamilton CA; Maxwell GL; Conrads TP
Hum Cell; 2017 Jul; 30(3):226-236. PubMed ID: 28251557
[TBL] [Abstract][Full Text] [Related]
20. FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma.
Zhong CQ; Zhang XP; Ma N; Zhang EB; Li JJ; Jiang YB; Gao YZ; Yuan YM; Lan SQ; Xie D; Cheng SQ
Cancer Med; 2018 Jun; 7(6):2629-2640. PubMed ID: 29733540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
